Milestone-Based Federal R&D Awards May Create Cash-Flow Gaps for Biotechs
A small biotech employee raised concerns that companies may need several million dollars in working capital before reaching the first accepted milestone and payment on ARPA-H- or DARPA-associated R&D awards. The post does not confirm payment delays or identify financing solutions, but highlights cash-flow exposure contractors should assess when evaluating award feasibility.